| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/12/2011 | CN101260040B 5/7/6 type taxane diterpenoid, and medicament composition, synthesizing method and use thereof |
| 01/12/2011 | CN101240007B Oleanane triterpene compound with containing multiple unsaturated double bonds and use thereof |
| 01/12/2011 | CN101239187B Functionalization carbon nano-tube for tumor lympha targeted therapeutic carrier |
| 01/12/2011 | CN101234128B Paederus extraction liquid and application thereof |
| 01/12/2011 | CN101157729B Tumour putrescence gene related apoptosis ligand variant and uses thereof |
| 01/12/2011 | CN101081848B Novel polyenes and preparation method and usage thereof |
| 01/12/2011 | CN101045721B Preparation of porcelain vine element unsaturated sodium salt and its application |
| 01/12/2011 | CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives |
| 01/12/2011 | CN101020719B Composite angelica polysaccharide and its preparation process and use |
| 01/11/2011 | US7868205 N-[2-amino-5-(2-thienyl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide; antiproliferative, antiprotozoal agent; lymphoma, lung cancer, colon cancer, prostrate cancer, stomach cancer, breast cancer, leukemia |
| 01/11/2011 | US7868204 Inhibitors of histone deacetylase |
| 01/11/2011 | US7868177 protein kinase inhibitors such as N-(4-((3-(2-(methylamino)-4-pyrimidinyl)-2-pyridinyl)oxy)-1-naphthalenyl)-1H-benzimidazol-2-amine, used for the treatment of breast cancer or rheumatoid arthritis; anticarcinogenic agents; antiarthritic agents |
| 01/11/2011 | US7868160 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 01/11/2011 | US7868040 Anti-cancer combinations |
| 01/11/2011 | US7868039 Anti-cancer combinations |
| 01/11/2011 | US7868018 such as N [3-(2-(3-trifluoromethyl)-benzoylamino -[1,6]naphthyridin-3-yl)-2,4-dichloro-phenyl]-3-trifluoromethyl-benzamide, used as antiproliferative agents or for the treatment of autoimmune diseases and nervous system disorders |
| 01/11/2011 | US7868011 Hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 01/11/2011 | US7868005 Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | US7868001 such as 2-(3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)imidazo[1,2-b]pyridazine, used for decreasing the levels of tumor necrosis factors or interleukines; treatment of inflammation, autoimmune diseases, diabetes, atherosclerosis and cancer |
| 01/11/2011 | US7867519 Method for the acceleration or deceleration of angiogenesis using fibrin matrix formed from increased or decreased HMW/LMW fibrinogen ratio |
| 01/11/2011 | US7867488 Use of dendritic cells (DCs) expressing interleukin 12 (IL-12) |
| 01/11/2011 | CA2577310C Methods and compositions for oral delivery of fts |
| 01/11/2011 | CA2503371C Quinazoline derivatives as src tyrosine kinase inhibitors |
| 01/11/2011 | CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative |
| 01/11/2011 | CA2468824C Hexacyclic compounds |
| 01/11/2011 | CA2462390C Anthranilic acid amides and pharmaceutical use thereof |
| 01/11/2011 | CA2453974C 4-(benzylideneamino)-3-(methylsulfanyl)-4h-1,2,4-triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/11/2011 | CA2420592C Fused pyrrolocarbazoles against inflammation |
| 01/11/2011 | CA2407593C Fused heteroaryl derivatives |
| 01/11/2011 | CA2400486C Aniline-derived ligands for the thyroid receptor |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/11/2011 | CA2349406C Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 01/11/2011 | CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/11/2011 | CA2309541C Vegi, an inhibitor of angiogenesis and tumor growth |
| 01/11/2011 | CA2156360C Adhesion receptor antagonists |
| 01/10/2011 | CA2709292A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/06/2011 | WO2011003065A2 Pyrazolopyrimidine jak inhibitor compounds and methods |
| 01/06/2011 | WO2011002887A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS |
| 01/06/2011 | WO2011002852A2 Pro-drug complexes and related methods of use |
| 01/06/2011 | WO2011002184A2 Phosphoric acid ester of bicalutamide for treating prostate cancer |
| 01/06/2011 | WO2011002077A1 Tnf-α gene therapy agent contained in polymeric micelle |
| 01/06/2011 | WO2011001403A1 Protein with apoptotic activity on cancer cells, its preparation and use |
| 01/06/2011 | WO2011001212A1 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation |
| 01/06/2011 | WO2011001122A2 Pyrazole derivatives, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | WO2011001115A1 Novel 6-morpholin-4-yl-pyrimidin-4-(3h)-one derivatives, and the pharmaceutical preparation thereof as akt(pkb) phosphorylation inhibitors |
| 01/06/2011 | WO2011001114A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors |
| 01/06/2011 | WO2011001113A2 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |
| 01/06/2011 | WO2011001109A1 Methods and compositions for treating cancer |
| 01/06/2011 | WO2011001097A1 Dermaseptin b2 used as an inhibitor of the growth of a tumor |
| 01/06/2011 | WO2011001089A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/06/2011 | WO2011001088A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/06/2011 | WO2011001052A1 Novel conjugates, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | WO2011000905A1 Substituted 2-carboxamide cycloamino ureas |
| 01/06/2011 | WO2011000855A1 2-carboxamide cycloamino ureas useful as pi3k inhibitors |
| 01/06/2011 | WO2011000811A2 Organic compounds |
| 01/06/2011 | WO2011000384A1 Method for suppressing tumor growth by blocking fibroblast growth factor receptor, and method for diagnosing malignant neoplasms |
| 01/06/2011 | WO2011000107A1 Novel lipid formulations for delivery of therapeutic agents to solid tumors |
| 01/06/2011 | WO2011000104A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones |
| 01/06/2011 | WO2010132684A9 Inhibitors of inv(16) leukemia |
| 01/06/2011 | WO2010132554A3 Diaza heterocyclic compounds for phototherapy |
| 01/06/2011 | WO2010130934A3 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole derivatives, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | WO2010125462A3 Pentamidine combinations for treating cancer |
| 01/06/2011 | WO2010121225A3 Method of treating disorders associated with protein kinase ck2 activity |
| 01/06/2011 | WO2010119991A3 Anti-hgf antibody combinational cancer therapies |
| 01/06/2011 | WO2010115555A3 Antibodies against human tweak and uses thereof |
| 01/06/2011 | WO2010107251A3 Pharmaceutical composition used in prophylaxis or treatment of hyperproliferative skin conditions and malignant melanomas comprising pachastrissamine as active ingredient |
| 01/06/2011 | WO2010104819A3 Hollow gold nanospheres (haunss) and haunss-loaded microspheres useful in drug delivery |
| 01/06/2011 | WO2010101994A3 Gene fusion targeted therapy |
| 01/06/2011 | WO2010099515A3 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo |
| 01/06/2011 | WO2010098627A3 Pharmaceutical preparation |
| 01/06/2011 | WO2010098613A3 Tm7sf3 composition for diagnosing liver cancer, diagnostic kit containing anti-tm7sf3 antibodies, and pharmaceutical composition for preventing or treating liver cancer |
| 01/06/2011 | WO2010090498A3 Pharmaceutical composition and health food composition containing youngia denticulata extract, fraction thereof, or compound isolated therefrom as active ingredient for improving liver function |
| 01/06/2011 | WO2010086880A4 A medical device loaded with formulations for targeted delivery of biologically active material/s and method of manufacture thereof |
| 01/06/2011 | WO2010081825A3 Pirenzepine as an agent in cancer treatment |
| 01/06/2011 | WO2010056985A8 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 01/06/2011 | WO2010028216A3 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 01/06/2011 | WO2010001119A3 Use of glucosinolates from cruciferous plants in modifying extracellular signalling proteins |
| 01/06/2011 | WO2010000364A8 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 01/06/2011 | US20110004949 Immunoglobulin 1 |
| 01/06/2011 | US20110004948 Immunoglobulin 2 |
| 01/06/2011 | US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 01/06/2011 | US20110003888 Hops extraction methods and mixtures |
| 01/06/2011 | US20110003887 Treating oncogenic ras driven cancers |
| 01/06/2011 | US20110003882 RNAi Modulation of AHA and Therapeutic Uses Thereof |
| 01/06/2011 | US20110003881 Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression |
| 01/06/2011 | US20110003879 Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof |
| 01/06/2011 | US20110003878 Novel derivatives of phthalimide as histone deacetylase inhibitors |
| 01/06/2011 | US20110003877 SMAC Mimetic |
| 01/06/2011 | US20110003874 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 01/06/2011 | US20110003861 2-aryl and 2-heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain |
| 01/06/2011 | US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/06/2011 | US20110003859 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer |
| 01/06/2011 | US20110003858 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
| 01/06/2011 | US20110003854 Breast cancer treatment and treatment prediction |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003842 Marker for determination of sensitivity to anti-cancer agent |
| 01/06/2011 | US20110003839 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |